<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: bone metastasis</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>MicroRNA molecule may serve as biomarker, target for brain metastases in breast cancer patients</title>
   	 <description>Researchers have identified two molecules that could potentially serve as biomarkers in predicting brain metastases in patients with breast cancer, according to data published in Cancer Research, a publication of the American Association for Cancer Research.</description>
     <link>http://medicalxpress.com/news/2013-02-microrna-molecule-biomarker-brain-metastases.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 05 Feb 2013 13:00:01 EST</pubDate>
	 <guid isPermaLink="false">news279282485</guid>
	 
</item>
<item>
     <title>Discovery reveals important clues to cancer metastasis</title>
   	 <description>In recent years investigators have discovered that breast tumors are influenced by more than just the cancer cells within them. A variety of noncancerous cells, which in many cases constitute the majority of the tumor mass, form what is known as the &quot;tumor microenvironment.&quot; This sea of noncancerous cells and the products they deposit appear to play key roles in tumor pathogenesis.</description>
     <link>http://medicalxpress.com/news/2012-10-discovery-reveals-important-clues-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 11 Oct 2012 13:44:38 EST</pubDate>
	 <guid isPermaLink="false">news269181849</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/discoveryrev.jpg" width="90" height="90" />
</item>
<item>
     <title>Heparin-like compounds inhibit breast cancer metastasis to bone</title>
   	 <description>Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a novel mechanism regulating the development of breast cancer bone metastases and showed that heparin-like compounds can potentially be used to inhibit breast cancer metastasis to bone.</description>
     <link>http://medicalxpress.com/news/2012-05-heparin-like-compounds-inhibit-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 21 May 2012 10:23:06 EST</pubDate>
	 <guid isPermaLink="false">news256814519</guid>
	 
</item>
<item>
     <title>Novel technology allows for noninvasive imaging of prostate cancer</title>
   	 <description>Use of a novel, noninvasive imaging tool allowed researchers to measure free prostate-specific antigen in prostate cancer models and to visualize bone metastasis in a tumor-specific manner, according to results published in Cancer Discovery, a journal of the American Association for Cancer Research.</description>
     <link>http://medicalxpress.com/news/2012-04-technology-noninvasive-imaging-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 02 Apr 2012 06:30:01 EST</pubDate>
	 <guid isPermaLink="false">news252566238</guid>
	 
</item>
<item>
     <title>Telomere failure, telomerase activation drive prostate cancer progression</title>
   	 <description>Genomic instability caused by an erosion of the protective caps on chromosomes, followed by activation of an enzyme that reinforces those caps, allows malignant cells to evade destruction and acquire more deadly characteristics, researchers report in an Online Now article at the journal Cell.</description>
     <link>http://medicalxpress.com/news/2012-02-telomere-failure-telomerase-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 21 Feb 2012 10:39:27 EST</pubDate>
	 <guid isPermaLink="false">news249043161</guid>
	 
</item>
<item>
     <title>Four new drugs will change prostate cancer care</title>
   	 <description>After a decade and a half of near stagnation, four new drugs could help make advanced prostate cancer a chronic illness instead of a terminal disease, a leading Colorado prostate cancer expert says.</description>
     <link>http://medicalxpress.com/news/2012-02-drugs-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 16 Feb 2012 14:11:39 EST</pubDate>
	 <guid isPermaLink="false">news248623872</guid>
	 
</item>
<item>
     <title>UK researchers present findings from Kentucky breast cancer patients with disease relapse</title>
   	 <description>The University of Kentucky Markey Cancer Center breast oncologist Dr. Suleiman Massarweh and his research team presented findings from their studies on relapse of breast cancer at the San Antonio Breast Cancer Symposium this month.</description>
     <link>http://medicalxpress.com/news/2011-12-uk-kentucky-breast-cancer-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 23 Dec 2011 09:56:00 EST</pubDate>
	 <guid isPermaLink="false">news243856552</guid>
	 
</item>
<item>
     <title>Denosumab delays development of prostate cancer bone metastasis</title>
   	 <description>An international clinical trial has found that treatment with a drug that suppresses the normal breakdown of bone can delay the development of bone metastases in men with prostate cancer. The study, receiving Online First publication in The Lancet, is the first to successfully reduce bone metastasis in such patients and supports the importance of targeting the bone microenvironment to prevent prostate tumor spread.</description>
     <link>http://medicalxpress.com/news/2011-11-denosumab-prostate-cancer-bone-metastasis.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 16 Nov 2011 05:18:22 EST</pubDate>
	 <guid isPermaLink="false">news240643096</guid>
	 
</item>
<item>
     <title>More radionuclide therapy is better for prostate cancer patients</title>
   	 <description>For prostate cancer patients with bone metastases, repeated administrations of radionuclide therapy with 188Re-HEDP are shown to improve overall survival rates and reduce pain, according to new research published in the November issue of The Journal of Nuclear Medicine.</description>
     <link>http://medicalxpress.com/news/2011-11-radionuclide-therapy-prostate-cancer-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 01 Nov 2011 10:21:45 EST</pubDate>
	 <guid isPermaLink="false">news239361694</guid>
	 
</item>
<item>
     <title>Brisk walking could improve prostate cancer outcomes</title>
   	 <description>Men with prostate cancer can improve their outcomes if they walk briskly for at least three hours a week following their diagnosis, according to a recent study in Cancer Research, a journal of the American Association for Cancer Research.</description>
     <link>http://medicalxpress.com/news/2011-05-brisk-prostate-cancer-outcomes.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 24 May 2011 13:14:18 EST</pubDate>
	 <guid isPermaLink="false">news225461637</guid>
	 
</item>


</channel>
</rss>
